Cemal Bes

Prof. Dr. Cemal Bes


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 August 2009 in Rheumatology International
Verified
Journal Article
Closed access
CBCemal Bes
Cemal Bes
MSMehmet Soy
Mehmet Soy
SVSeref Vardi
Seref Vardi
NSNeriman Sengul
Neriman Sengul
FYFahri Yilmaz
Fahri Yilmaz

22 March 2021 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MSMehmet Soy
Mehmet Soy
GKGökhan Keser
Gökhan Keser
PAPamir Atagunduz
Pamir Atagunduz
MMMelek Yalcin Mutlu
Melek Yalcin Mutlu
AGAlper Gunduz
Alper Gunduz
CBCemal Bes
Cemal Bes

21 October 2009 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
CBCemal Bes
Cemal Bes
MSMehmet Soy
Mehmet Soy

3 September 2019 in European Journal of Rheumatology
Verified
Journal Article
Open access
CBCemal Bes
Cemal Bes
Interstitial lung disease (ILD) is one of the extra-articular involvement forms of rheumatoid arthritis (RA), and it is associated with increased mortality. The presence of genetic susceptibility, smoking, rheumatoid factor positivity, and the presence of anticitrulline peptide antibodies are factors contributing to the development of ILD in patients with RA. Early diagnosis and treatment of ILD contribute to the reduction of morbidity and mortality. We herein evaluated the current literature for the diagnosis and treatment of RA-associated ILD. Cite this article as: Bes C. Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis. Eur J Rheumatol 2019; 6(3): 146-9.

27 March 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
CBCemal Bes
Cemal Bes
ÜDÜlkü Dağlı
Ülkü Dağlı
PMPınar Memedoğlu
Pınar Memedoğlu
MSMehmet Soy
Mehmet Soy